Form EFFECT Allarity Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 5, 2025 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
- Breeze Acquisition Corp. II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Reports on Form 10-Q
- Fall 2026 New Trend: Relaxed Elegance Takes Center Stage – Zeagoo’s Autumn Collection Unlocks the Modern Woman’s Effortless Wardrobe
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
